Priority-driven Collaborative Cancer Research Scheme

Cancer Australia has established the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.

Overview

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.

This funding scheme helps to:

  • coordinate funding of priority-driven cancer research at the national level,
  • foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
  • foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency collaborates with the NHMRC in this grant scheme. The NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.

Successful applicants for 2018 Round

On 21 December 2018, the Australian Government announced successful applicants for the 2018 round of the Priority-driven Collaborative Cancer Research Scheme, proudly funded by Cancer Australia, Cancer Council Australia, Children’s Hospital Foundation, Cure Cancer Australia, Leukaemia Foundation of Australia, My Room, Pancare Foundation, and The Kids’ Cancer Project.

The successful grants in the 2018 round of the PdCCRS are as follows:

Adams, Mark
Queensland University of Technology
Enhancing non-small cell lung cancer sensitivity to front-line chemotherapy by exploiting cell cycle checkpoint factors
Funded by: Cure Cancer Australia

Bray, Laura
Queensland University of Technology
Development of a translational bioengineered microenvironment model to advance pre-clinical acute myeloid leukaemia research
Funded by: Cancer Australia and Leukaemia Foundation of Australia

Brumatti, Gabriela
The Walter and Eliza Hall Institute of Medical Research
Targeting multidrug resistance protein 1 (MDR1) enhances the efficacy of Smac-mimetic-based therapy in Acute Myeloid Leukaemia
Funded by: Cancer Australia and Leukaemia Foundation of Australia

Cowley, Mark
Children’s Cancer Institute
Decoding the Dark Matter of the High-Risk Paediatric Cancer Genome
Funded by: Cancer Australia and My Room

Da Gama Duarte, Jessica
Olivia Newton-John Cancer Research Institute
Measuring immune engagement to predict clinical responses to immunotherapy.
Funded by: Cure Cancer Australia

Ebert, Martin
University of Western Australia
Mixed radiotherapy fractionation: modulating tumour microenvironment to stimulate and enhance immunotherapy
Funded by: Cancer Australia

Edgington-Mitchell, Laura
Bio21 Institute
Proteases and PAR2 are key mediators of cancer pain
Funded by: Cancer Australia and Cure Cancer Australia

Grimison, Peter
Chris O’Brien Lifehouse
P3BEP Trial: Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours: An Australian-Led, International Randomised Trial
Funded by: Cancer Australia

Guimaraes, Fernando
University of Queensland Diamantina Institute
Targeting alternative SMAD-related suppressive signalling pathway enhance NK cell response
Funded by: Cancer Australia and Cure Cancer Australia

Hancock, Sarah
University of New South Wales
Understanding metabolite heterogeneity in pancreatic ductal adenocarcinoma, and its role in adaptive metabolic reprogramming during chemotherapy treatment
Funded by: Cure Cancer Australia

Hayes, Sandra
Queensland University of Technology
The ECHO trial: Exercise during CHemotherapy for Ovarian cancer
Funded by: Cancer Australia

Henderson, Michelle
University of New South Wales
Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children
Funded by: Cancer Australia, The Kids’ Cancer Project and Leukaemia Foundation of Australia

Holien, Jessica
St Vincent’s Institute of Medical Research
Targeting key protein-protein interactions in Neuroblastoma
Funded by: Cure Cancer Australia

Hovey, Elizabeth
Prince of Wales Hospital
Personalised targeted therapy for adolescent and young adult medulloblastoma patients
Funded by: Cancer Australia and The Kids’ Cancer Project

Jacquelot, Nicolas
The Walter and Eliza Hall Institute of Medical Research
Definition of the role of key Innate Lymphoid Cell regulators in melanoma control
Funded by: Cancer Australia and Cure Cancer Australia

Jefford, Michael
Peter MacCallum Cancer Centre
SCORE: Shared care of Colorectal cancer survivors – A randomised controlled trial of hospital-based follow up versus shared hospital / general practice follow up for survivors of colorectal cancer (CRC)
Funded by: Cancer Australia

Jenkins, Misty
The Walter and Eliza Hall Institute of Medical Research
Designing Chimeric Antigen Receptor T cells for Diffuse Intrinsic Pontine Glioma
Funded by: Cancer Australia

Kahl, Vivian
Children’s Medical Research Institute
Developing telomere fibre analysis to measure telomere length dynamics in cancer cells
Funded by: Cure Cancer Australia

Keane, Colm
The University of Queensland
Investigation of the key immuno-genetic drivers of Primary Central Nervous System Lymphoma that occurs in patients with HIV infection
Funded by: Cancer Australia and Cure Cancer Australia

Kisely, Steve
The University of Queensland
What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
Funded by: Cancer Council Australia

Lindeman, Geoffrey
The Walter and Eliza Hall Institute of Medical Research
Targeting BCL-2 in estrogen receptor positive breast cancer
Funded by: Cancer Australia

Martin, Jarad
Calvary Mater Newcastle
Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation (NINJA)
Funded by: Cancer Australia

Nassar, Zeyad
The University of Adelaide
Targeting polyunsaturated fatty acid metabolism to overcome prostate cancer treatment resistance
Funded by: Cure Cancer Australia

Nguyen, Linh
University of Melbourne
Novel mammographic density measures, Pike’s model of breast tissue ageing, and other risk factors for breast cancer
Funded by: Cure Cancer Australia

O’Brien, Ricky
University of Sydney, Image X Institute
Improving tumour targeting and delineation in lung cancer radiotherapy
Funded by: Cancer Australia

Poh, Ashleigh
Olivia Newton-John Cancer Research Institute
Targeting HCK in pancreatic ductal adenocarcinoma to restrict tumour growth and metastasis
Funded by: Cancer Australia, Cure Cancer Australia and Pancare Foundation

Raninga, Prahlad
QIMR Berghofer Medical Research Institute
A novel proteasome inhibitor to treat basal-like primary and metastatic triple-negative breast cancers
Funded by: Cure Cancer Australia

Symonds, Erin
Flinders University
Personalising treatment and surveillance for colorectal cancer: prognostication with the circulating tumour-derived methylated DNA markers BCAT1 and IKZF1
Funded by: Cancer Australia

Vandyke, Kate
The University of Adelaide
N-cadherin inhibitors as vascular disrupting agents: increasing drug delivery to tumours and improving quality of life for cancer patients
Funded by: Cancer Australia, Cure Cancer Australia and Leukaemia Foundation of Australia

Vine, Kara
Illawarra Health and Medical Research Institute
Implantable drug-eluting device: localised drug delivery for non-resectable pancreatic cancer
Funded by: Pancare Foundation

Wainwright, Brandon
The University of Queensland
Exploiting CDK4/6 inhibition to treat medulloblastoma
Funded by: Cancer Australia, The Kids’ Cancer Project  and Children’s Hospital Foundation

Wang, Jenny
Children’s Cancer Institute
Therapeutic targeting of a novel self-renewal signalling in leukaemia stem cells
Funded by: Cancer Australia and Leukaemia Foundation of Australia

Weeden, Clare
The Walter and Eliza Hall Institute of Medical Research
Deep molecular profiling of primary lung cancers, their metastases and the immune microenvironment to identify novel therapeutic targets
Funded by: Cure Cancer Australia

Ziegler, David
Sydney Children’s Hospital
Targeting Polo-like kinase 1 as a novel therapeutic opportunity for Diffuse Intrinsic Pontine Gliomas
Funded by: Cancer Australia and The Kids’ Cancer Project


Cancer Australia's funding partners and successful applicants in previous PdCCRS rounds

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Find out more about: